Volume : 09, Issue : 09, September – 2022
02.STUDY ON INDIAN MEDICAL DEVICE LEGISLATIONS IN COMPARISION WITH UNITED STATES OF AMERICA AND EUROPEAN UNION WITH SPECIFIC REFERENCE TO SELECTED HIGH RISK MEDICAL DEVICES
R GNANA RAMYA*, M. V. NAGABHUSHANAM, Y. RATNA SINDHU, T SUKANYA, SK SANJUDA, BRAHMAIAH BONTHAGARALA, G. RAMAKRISHNA
In order to market any medical device, marketing authorization from Regulatory authority is required. The process of gaining authorization is complex, multistep and requires review of information by competent authorities. Upon scrutinizing the information furnished by Manufacturer, marketing authorization is granted by the concerned Regulatory authority. In the USA, manufacturers are required to apply to United States Food and Drugs Application (USFDA) for Marketing Authorization. There are two types of applications in USA; 510 (k) and Pre-Market Application (PMA). In EU, National Authorities give approval for marketing medical devices. A system of third party compliance is followed, where Notified Bodies (Third Party) ensure Quality Assurance, pre and post approval. In India, Central Drugs Standard Control Organization (CDSCO) approves devices for sale and import. Medical Devices are regulated under CLAA scheme. The Drug Controller General of India (DCGI) is the central licensing authority for medical devices. This paper attempts to capture information on regulations of Medical Device in three regions namely; USA, EU and India and compare provisions of Market authorization in the respective regions, and further, for the readers, make this complex subject easier to grasp.
Keywords: In vitro diagnostics, Indian regulations, medical device regulations, medical device rules 2017, medical devices.
Cite This Article:
Please cite this article in press R Gnana Ramya et al, Study On Indian Medical Device Legislations In Comparison With United States Of America And European Union With Specific Reference To Selected High Risk Medical Devices., Indo Am. J. P. Sci, 2022; 09(9).
Number of Downloads : 10
1. Deloitte, NATHEALTH Medical devices making in India-a leap for Indian healthcare. 2016. [Last accessed on 2021 Mar 04]. Available from: https://www2.deloitte.com/content/dam/Deloitte/in/Documents/life-sciences-health-care/in-lshc-medical-devices-making-in-india-noexp.pdf .
2. India – Overview of Medical Device Industry and Healthcare Statistics. Available via EMERGO. 2016. Jul, [Last accessed on 2020 Jun 30]. Available from: https://www.emergobyul.com/resources/market-india .
3. Union Budget of India 2020-21, Rebuilding Momentum. Available via PricewaterhouseCoopers Private Limited. 2020. Feb, [Last accessed on 2020 Jun 20]. Available from: https://www.pwc.in/assets/pdfs/budget/2020/pwc-union-budget-analysis.pdf.
4. Markan S, Verma Y. Indian medical device sector: Insights from patent filing trends. BMJ Innov. 2017;3:167–75. [Google Scholar]
5. Medical Device Rules, 2017: Ministry of Health and Family Welfare, Government of India. Available via CDSCO. [Last accessed on 2020 Jun 08]. Available from: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medical-Device-Diagnostics/
6. Medical Devices (Amendment) Rules, 2020: Ministry of Health and Family Welfare, Government of India. Available via CDSCO. [Last accessed on 2020 Jun 08]. Available from: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medical-Device-Diagnostics/
7. Brahmaiah Bonthagarala, Regulatory Requirements for Registration of Generic Drugs in “BRICS” Countries, International Journal of Pharmaceutical Science and Health Care, ISSN 2249 – 5738, Issue 6, Vol. 6 (November-December 2016), 20-39.
8. Brahmaiah Bonthagarala, Current Regulatory Requirements for Registration of Medicines, Compilation and Submission of Dossier in Australian Therapeutic Goods Administration, International Journal of Advanced Scientific and Technical Research, ISSN 2249-9954, Issue 6 volume 6, November-December 2016, 144-157.
9. Brahmaiah Bonthagarala, Comparison of Regulatory Requirements for Generic Drugs Dossier Submission in United States and Canada, International Journal of Pharmaceutical Science and Health Care, ISSN 2249 – 5738, Issue 6, Vol. 6 (November-December 2016), 1-19.
10. Brahmaiah Bonthagarala, Nanomedicine Clinical Use, Regulatory and Toxicology Issues In Europe, Journal of Drug Delivery and Therapeutics, 2019; 9(4-s):846-848.
11. Brahmaiah Bonthagarala, A Review on global harmonization task force (GHTF) – principles of in vitro diagnostic (IVD) medical devices classification, The Pharma Innovation Journal 2018; 7(7): 667-672, ISSN (E): 2277- 7695.
12. Brahmaiah Bonthagarala, Compilation of Chemistry Manufacturing Controls In Abbreviated New Drug Application, Journal of Pharma Research, Vol-08, Issue 08, 2019.
14. Ministry of Health and Family Welfare (2013) Guidance Document on Common Submission Format for Import License of Non Notified Diagnostic kits in India. Central Drugs Standard Control Organization.
16. http://companiesinindia.net/top-10-medical-device-companies-in- india.html
17. World Health Organization (2010) Clinical evidence for medical devices: Regulatory processes focussing on Europe and the United States of America. Medical Devices.
18. Ministry of Health and Family Welfare (2010) Guidance document on application for grant of Licence in Form-28 for manufacture of Medical Devices in India under CLAA Scheme. Central Drugs Standard Control Organization.
19. Ministry of Health and Family Welfare (2012) Guidance Document on Common Submission Format for Import License in Form-10 of Notified Medical Devices in India. Central Drugs Standard Control Organization.
20. European Council (2007) Council Directive of 14th June 1993 concerning medical devices. Council of the European Communities.